• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Legal Officer Burd Brad covered exercise/tax liability with 814 shares, decreasing direct ownership by 0.52% to 157,070 units (SEC Form 4)

    5/7/25 2:04:59 PM ET
    $GOCO
    Specialty Insurers
    Finance
    Get the next $GOCO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Burd Brad

    (Last) (First) (Middle)
    222 W MERCHANDISE MART PLAZA, SUITE 1750

    (Street)
    CHICAGO IL 60654

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    GoHealth, Inc. [ GOCO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Legal Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    05/05/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 05/05/2025 F 814(1) D $7.75 157,070 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of 2,778 restricted stock units granted to the reporting person on June 21, 2022.
    Remarks:
    /s/ Bradley Burd 05/07/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GOCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GOCO

    DatePrice TargetRatingAnalyst
    4/1/2022$1.50Underperform
    Credit Suisse
    3/3/2022$10.00 → $2.00Outperform → Sector Perform
    RBC Capital
    3/2/2022Buy → Hold
    Truist
    3/2/2022$2.00Buy → Hold
    Truist Securities
    1/7/2022$6.00 → $3.00Neutral → Underperform
    Credit Suisse
    1/5/2022$7.50 → $3.50Buy → Underperform
    B of A Securities
    11/15/2021$7.00 → $6.00Neutral
    Credit Suisse
    11/11/2021$13.00 → $5.50Equal-Weight
    Morgan Stanley
    More analyst ratings

    $GOCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

      SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

      8/25/23 6:15:20 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

      SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

      8/25/23 6:03:57 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

      SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

      5/19/23 6:08:49 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • GoHealth's Statement on Recent Allegations in the United States False Claims Act Complaint

      CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, firmly denies the allegations made by the Government in a lawsuit in which the company has been named as a defendant related to events that allegedly occurred between 2016 and 2021. We are disappointed that the Government is pursuing claims against a company that has at all times worked to advance the interests of the Medicare Advantage program and the Medicare beneficiaries it serves. GoHealth maintains that it complied with the laws that were specifically designed by Congress and HHS to address payments by Medicare Advanta

      5/7/25 8:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth to Announce First Quarter 2025 Results on May 13, 2025

      CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its first quarter 2025 financial results on the morning of May 13, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand listening

      5/5/25 9:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment Period

      CHICAGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2024. Fourth Quarter Highlights Achieved net revenues of $389.1 million, a substantial 41% increase compared to the prior year period. Submissions grew to 481,445, representing a 67% increase compared to the prior year period. Net income of $58.0 million, a substantial improvement of $60.3 million compared to the prior year period. Adjusted EBITDA1 surged to $117.8 million, a significant 107% increase compared to the

      2/27/25 7:00:36 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kotte Vijay bought $100,275 worth of shares (7,500 units at $13.37), increasing direct ownership by 1% to 653,630 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      11/15/23 10:10:34 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Financials

    Live finance-specific insights

    See more
    • GoHealth to Announce First Quarter 2025 Results on May 13, 2025

      CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its first quarter 2025 financial results on the morning of May 13, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand listening

      5/5/25 9:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment Period

      CHICAGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2024. Fourth Quarter Highlights Achieved net revenues of $389.1 million, a substantial 41% increase compared to the prior year period. Submissions grew to 481,445, representing a 67% increase compared to the prior year period. Net income of $58.0 million, a substantial improvement of $60.3 million compared to the prior year period. Adjusted EBITDA1 surged to $117.8 million, a significant 107% increase compared to the

      2/27/25 7:00:36 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025

      CHICAGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its fourth quarter 2024 financial results on the morning of February 27, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand li

      2/13/25 4:30:00 PM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Credit Suisse resumed coverage on GoHealth with a new price target

      Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50

      4/1/22 7:10:27 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth downgraded by RBC Capital with a new price target

      RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously

      3/3/22 4:36:13 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth downgraded by Truist

      Truist downgraded GoHealth from Buy to Hold

      3/2/22 7:31:46 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    SEC Filings

    See more
    • SEC Form DEF 14A filed by GoHealth Inc.

      DEF 14A - GoHealth, Inc. (0001808220) (Filer)

      4/28/25 9:14:18 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form DEFA14A filed by GoHealth Inc.

      DEFA14A - GoHealth, Inc. (0001808220) (Filer)

      4/28/25 9:14:36 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - GoHealth, Inc. (0001808220) (Filer)

      4/7/25 5:23:23 PM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Legal Officer Burd Brad covered exercise/tax liability with 814 shares, decreasing direct ownership by 0.52% to 157,070 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      5/7/25 2:04:59 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • Chief Executive Officer Kotte Vijay covered exercise/tax liability with 24,612 shares, decreasing direct ownership by 2% to 1,221,491 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      4/14/25 1:50:52 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • Chief Executive Officer Kotte Vijay was granted 500,000 shares and covered exercise/tax liability with 221,500 shares, increasing direct ownership by 29% to 1,246,103 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      4/7/25 4:40:00 PM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy

      CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t

      10/10/24 9:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Appoints Vance Johnston as Chief Financial Officer

      CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021.  As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou

      12/6/21 4:05:00 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Appoints Dr. Paul Hain, M.D. as Chief Medical Officer

      CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he

      12/1/20 8:06:00 AM ET
      $GOCO
      Specialty Insurers
      Finance